JETEX CHRISTMAS IN THE SKY

Dubai, United Arab Emirates, Dec. 27, 2021 (GLOBE NEWSWIRE) — For the wealthiest of the wealthy, only the most extravagant and expensive gifts are acceptable during the holiday giving season. This inspired Jetex to design the ultimate ‘Christmas in the Sky’ private jet experience, priced USD 27,000 for up to 10 passengers. Jetex, an award-winning […]

Continue Reading

‫Maypharm تطلق مجموعة احترافية جديدة HAIRNA لحل تساقط الشعر

سيول، كوريا الجنوبية ونيويورك، 24 ديسمبر 2021 /PRNewswire/ — تُعرف شركة Maypharm كشركة مصنعة لتوكسين البوتولينوم Metox الذي تم إطلاقه مؤخرًا بنجاح مع الجيل الثاني من الميزة التكنولوجية وحشو meNnus PLA لتجديد الكولاجين، يركز الآن على مجموعة احترافية جديدة HAIRNA لحل تساقط الشعر. يتكون خط إنتاج الشعر الجديد من 5 منتجات، منتج رئيسي هو HAIRNA EXOSOME AMPOULE (5 مل × […]

Continue Reading

FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product

VLN® Cigarettes VLN® Is World’s First and Only Combustible Cigarette to Receive FDA MRTP Designation FDA Adds Evidence-Based, Headline Claim “Helps You Smoke Less” to Company’s Requested Claims VLN® 95% Reduced Nicotine Content Cigarettes to Launch in the U.S. Within 90 Days VLN® to Launch Outside the U.S. in First Quarter 2022 BUFFALO, N.Y., Dec. […]

Continue Reading

Hitachi Energy wins major contract for the first-of-its-kind sub-sea power transmission network in the MENA region advancing a sustainable energy future for Abu Dhabi

HVDC Light® will connect low-carbon power from the mainland grid to ADNOC’s production operations as a strategic project to enable a sustainable, flexible and secure power supply. Zurich, Switzerland, Dec. 22, 2021 (GLOBE NEWSWIRE) — Hitachi Energy today announced it has won a major order from Samsung C&T Corporation, one of the world’s largest engineering […]

Continue Reading

HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention

DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) — Data from the HIV Prevention Trials Network (HPTN) studies HPTN 083 and HPTN 084 helped provide important information for yesterday’s decision by the U.S. Food and Drug Administration (FDA) to approve ViiV Healthcare’s long-acting cabotegravir (CAB-LA) injections for the prevention of HIV. Sponsored and co-funded by the […]

Continue Reading